Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma
β Scribed by Yoichi Mizutani; Hiroki Matsubara; Kosuke Yamamoto; Yong Nan Li; Kazuya Mikami; Koji Okihara; Akihiro Kawauchi; Benjamin Bonavida; Tsuneharu Miki
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 111 KB
- Volume
- 101
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: 5-fluorouracil (5-fu) is an anticancer agent clinically used against various cancers including bladder carcinoma. 5-fu inhibits thymidylate synthase (ts) and blocks dna synthesis. ts is the key enzyme in the catalysis of the methylation from deoxyuridine monophosphate (dump) to deoxy
## Abstract ## BACKGROUND Thymidine kinase (TK) plays a key role in the complimentary or alternative salvage pathway of pyrimidine synthesis. Little is known about the significance of TK activity in bladder carcinoma. The authors examined the activity of TK in 55 patients with bladder carcinoma to
## Abstract ## BACKGROUND 5βFluorouracil (5βFU), an antitumor agent, is used clinically against a variety of malignancies, including bladder carcinoma. 5βFU is a prodrug, and orotate phosphoribosyltransferase (OPRT) is the principal enzyme that converts 5βFU directly into an active antitumor metab